Cooper Companies
Cooper Companies, Inc. (NASDAQ: COO) is a leading global medical device company headquartered in San Ramon, California, with operations spanning over 130 countries and positively impacting more than fifty million lives annually. The company operates through two primary business segments: CooperVision and… From the company’s description.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What Cooper Companies does
In the company’s own words
Cooper Companies, Inc. (NASDAQ: COO) is a leading global medical device company headquartered in San Ramon, California, with operations spanning over 130 countries and positively impacting more than fifty million lives annually. The company operates through two primary business segments: CooperVision and CooperSurgical, which together provide comprehensive solutions in vision care, fertility, and women's health.
CooperVision manufactures and markets a broad range of contact lenses globally, including single-use, two-week, and monthly modalities featuring advanced silicone hydrogel materials and optics. The segment addresses vision challenges such as astigmatism, presbyopia, and myopia through spherical, toric, and multifocal lens designs. CooperVision's portfolio includes premium brands such as Biofinity, MyDay, and clariti 1 day, alongside specialty products including orthokeratology and scleral lenses. The company holds a significant competitive advantage through MiSight 1 day, the first and only FDA-approved contact lens for slowing myopia progression in children aged eight to twelve, with approvals also obtained in China and Japan. Major manufacturing and distribution facilities operate in Belgium, Costa Rica, Hungary, Puerto Rico, the United Kingdom, and the United States.
CooperSurgical offers over six hundred products and services focused on fertility and women's health, categorized into office and surgical products used by obstetricians and gynecologists, and fertility products and services utilized in fertility clinics. The segment's portfolio encompasses surgical instruments, contraception solutions including the hormone-free Paragard intrauterine device, cord blood and cord tissue cryostorage services, and comprehensive fertility support including donor gametes, cryopreservation, and genomic testing services. CooperSurgical maintains major facilities in Costa Rica, the Netherlands, the United Kingdom, and the United States.
The company employs approximately five hundred people in research and development across both segments. Cooper competes on the basis of product quality, technological differentiation, pricing, service levels, and manufacturing efficiency. The company maintains ISO 13485 certification and CE marks for its products, with additional ISO 15189 certification for genomics laboratories. Cooper's website is www.coopercos.com.
Company details
- Sector
- Health Care
- Industry (SIC)
- Medical Instruments
- Headquarters
- SAN RAMON, CA
- Fiscal year end
- October
- CIK
- 711404
- SIC
- 3851
Financial performance, year by year
Fiscal 2013–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Cooper Companies — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Superinvestors in Cooper Companies · what they did last quarter
Share of each manager’s reported 13F portfolio. Change is in shares held, since the previous quarter.
Largest fund holders · Cooper Companies’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Fund ownership is a subset of institutional 13F ownership — the two describe overlapping populations and must not be added together.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Cooper Companies and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Cooper Companies's earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Cooper Companies's last four quarterly filings that the numbers alone won't show?”